These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32477361)

  • 1. Evaluation of IL-1 Blockade as an Adjunct to Linezolid Therapy for Tuberculosis in Mice and Macaques.
    Winchell CG; Mishra BB; Phuah JY; Saqib M; Nelson SJ; Maiello P; Causgrove CM; Ameel CL; Stein B; Borish HJ; White AG; Klein EC; Zimmerman MD; Dartois V; Lin PL; Sassetti CM; Flynn JL
    Front Immunol; 2020; 11():891. PubMed ID: 32477361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of linezolid and second-line anti-tuberculosis agents against multidrug-resistant Mycobacterium tuberculosis in vitro and in vivo.
    Zhao W; Zheng M; Wang B; Mu X; Li P; Fu L; Liu S; Guo Z
    Int J Infect Dis; 2016 Nov; 52():23-28. PubMed ID: 27613365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Replacing Linezolid with OTB-658 in Anti-Tuberculosis Regimens in Murine Models.
    Liu H; Zhu H; Fu L; Zhang W; Chen X; Wang B; Guo S; Ding Y; Wang N; Li D; Lu Y
    Antimicrob Agents Chemother; 2023 Feb; 67(2):e0139922. PubMed ID: 36622240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of in vitro synergy between linezolid and other antimicrobial agents against Mycobacterium tuberculosis isolates.
    Zou L; Liu M; Wang Y; Lu J; Pang Y
    Tuberculosis (Edinb); 2015 Dec; 95(6):839-842. PubMed ID: 26395151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on the resistance of rifampicin-resistant Mycobacterium tuberculosis to anti-tuberculosis drugs in group A].
    Dai XW; Li CY; Wang NH; Chen SS; Tian LL; Zhao YF; Tao LY; Yang XY; Ding BC; He XX
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1110-1117. PubMed ID: 37914422
    [No Abstract]   [Full Text] [Related]  

  • 6. Activity of rifampicin and linezolid combination in Mycobacterium tuberculosis.
    Maltempe FG; Caleffi-Ferracioli KR; do Amaral RCR; de Oliveira Demitto F; Siqueira VLD; de Lima Scodro RB; Hirata MH; Pavan FR; Cardoso RF
    Tuberculosis (Edinb); 2017 May; 104():24-29. PubMed ID: 28454646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linezolid as a Potentially Effective Drug for the Treatment of Multidrug-Resistant Tuberculosis in Japan.
    Yi L; Yoshiyama T; Okumura M; Morimoto K; Sasaki Y; Shiraishi Y; Ogata H; Mitarai S
    Jpn J Infect Dis; 2017 Jan; 70(1):96-99. PubMed ID: 27000461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of linezolid-containing regimens against multidrug-resistant tuberculosis in mice.
    Zhao W; Guo Z; Zheng M; Zhang J; Wang B; Li P; Fu L; Liu S
    Int J Antimicrob Agents; 2014 Feb; 43(2):148-53. PubMed ID: 24290060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging threat of fluroquinolone-, bedaquiline-, and linezolid-resistant Mycobacterium tuberculosis in China: Observations on surveillance data.
    Li S; Tan Y; Deng Y; Bai G; Huang M; Shang Y; Wang Y; Xue Z; Zhang X; Wang W; Pan J; Pang Y
    J Infect Public Health; 2024 Jan; 17(1):137-142. PubMed ID: 38000314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linezolid in the treatment of extensively drug-resistant tuberculosis.
    Zhang L; Pang Y; Yu X; Wang Y; Gao M; Huang H; Zhao Y
    Infection; 2014 Aug; 42(4):705-11. PubMed ID: 24902521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Evaluation of Linezolid and Meropenem Against Clinical Isolates of Multi Drug Resistant Tuberculosis By Mycobacterial Growth Indicator Tube (MGIT) 960.
    Mirza IA; Satti L; Khan FA; Khan KA
    J Coll Physicians Surg Pak; 2015 Jun; 25(6):427-30. PubMed ID: 26100995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superior Efficacy of a TBI-166, Bedaquiline, and Pyrazinamide Combination Regimen in a Murine Model of Tuberculosis.
    Ding Y; Zhu H; Fu L; Zhang W; Wang B; Guo S; Chen X; Wang N; Liu H; Lu Y
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0065822. PubMed ID: 35924925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects of contezolid (MRX-I) against multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis.
    Yang M; Zhan S; Fu L; Wang Y; Zhang P; Deng G
    Drug Discov Ther; 2022 May; 16(2):99-101. PubMed ID: 35418550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linezolid resistance in
    Nambiar R; Tornheim JA; Diricks M; De Bruyne K; Sadani M; Shetty A; Rodrigues C
    Indian J Med Res; 2021 Jul; 154(1):85-89. PubMed ID: 34782533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcome, recurrence and safety of multidrug-resistant TB treated with low-dose linezolid.
    Chung C; Jo KW; Shim TS
    Int J Tuberc Lung Dis; 2023 Dec; 27(12):918-924. PubMed ID: 38042970
    [No Abstract]   [Full Text] [Related]  

  • 16. Decreased mortality seen in rifampicin/multidrug-resistant tuberculous meningitis treated with linezolid in Shenzhen, China.
    Fang MT; Su YF; An HR; Zhang PZ; Deng GF; Liu HM; Mao Z; Zeng JF; Li G; Yang QT; Wang ZY
    BMC Infect Dis; 2021 Sep; 21(1):1015. PubMed ID: 34583653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic-pharmacodynamic modeling of tuberculosis time to positivity and colony-forming unit to assess the response to dose-ranging linezolid.
    Simeon S; Garcia-Cremades M; Savic R; Solans BP
    Antimicrob Agents Chemother; 2024 Aug; 68(8):e0019024. PubMed ID: 39016594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility testing of extensively drug-resistant and pre-extensively drug-resistant Mycobacterium tuberculosis against levofloxacin, linezolid, and amoxicillin-clavulanate.
    Ahmed I; Jabeen K; Inayat R; Hasan R
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2522-5. PubMed ID: 23507286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying Regimens Containing TBI-166, a New Drug Candidate against
    Zhang Y; Zhu H; Fu L; Wang B; Guo S; Chen X; Liu Z; Huang H; Yang T; Lu Y
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic Correlates of Linezolid Activity and Toxicity in Murine Models of Tuberculosis.
    Bigelow KM; Deitchman AN; Li SY; Barnes-Boyle K; Tyagi S; Soni H; Dooley KE; Savic RM; Nuermberger EL
    J Infect Dis; 2021 Jun; 223(11):1855-1864. PubMed ID: 31993638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.